Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sisonke open-label trial of single-dose Ad26.COV2.S in South African health care workers
PACTR202102855526180Phase 3Unknown
- Sponsor
- South African Medical Research Council
- Start
- Mar 2021
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19), sponsored by South African Medical Research Council. Status: unknown.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202102855526180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202102855526180.